40 Hz Gamma Auditory Stimulation for Delirium Prevention in Critically Ill ICU Patients
Key facts
- Who runs it
- Peking Union Medical College Hospital
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 142 people, planned
- Started
- 31 Oct 2026
- Expected to end
- 31 Jan 2029
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- 40 Hz Gamma Auditory Stimulation
- Silent Audio Control
- Record updated
- 15 October 2026
Who can take part
- Age
- 50 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Expected duration of mechanical ventilation of at least 48 hours
- Age 50 years or older, with no upper age limit
Who cannot take part
- Previous treatment with antipsychotic medication
- Inability to wear earphones because of head trauma or surgery
- Known moderate-to-severe neurocognitive or psychiatric disorders that would confound delirium assessment, such as dementia or schizophrenia
- Severe or worse hearing impairment, defined as Grade 3 or higher according to the World Health Organization classification of hearing impairment
- Epilepsy or a history of epilepsy
- Moribund condition with an expected survival of no more than 24 hours
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Delirium is a common acute disturbance of attention and cognition among critically ill patients and is associated with prolonged mechanical ventilation, longer hospital stays, and increased mortality. This multicenter, quadruple-masked, randomized controlled trial will evaluate whether 40 Hz gamma auditory stimulation can help prevent delirium in mechanically ventilated adult ICU patients.
Read full original descriptionShow less
A total of 142 participants aged 50 years or older who are expected to require mechanical ventilation for at least 48 hours will be randomly assigned in a 1:1 ratio to receive either 40 Hz gamma auditory stimulation or a silent audio track, in addition to standard ICU care. The assigned intervention will be delivered through identical earphones twice daily at 08:00 and 20:00, for 60 minutes per session, until extubation or Day 7 after randomization, whichever occurs first.
The primary outcome is the number of delirium- and coma-free days during the first 7 days after randomization. Secondary outcomes include the incidence and duration of delirium during this period, duration of mechanical ventilation, length of ICU and hospital stay through Day 28, and 28-day all-cause mortality.
The 2 groups in the trial
- 40 Hz Gamma Auditory Stimulation GroupTreatment being tested
Participants receive 40 Hz isochronic tones presented synchronously to both ears through standardized high-fidelity wired in-ear noise-canceling earphones, in addition to standard ICU care. The auditory stimulus is delivered at 65-70 decibels (dB) twice daily at 08:00 and 20:00 for 60 minutes per session. The intervention continues until extubation or Day 7 after randomization, whichever occurs first.
Treatment: 40 Hz Gamma Auditory Stimulation
- Silent Audio Control GroupSham treatment, for comparison
Participants receive a silent audio track through standardized high-fidelity wired in-ear noise-canceling earphones, in addition to standard ICU care. The device, wearing procedure, session schedule, and duration are matched to the experimental group. Sessions are administered twice daily at 08:00 and 20:00 for 60 minutes per session until extubation or Day 7 after randomization, whichever occurs first.
Treatment: Silent Audio Control
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Efficacy of 40 Hz Gamma Auditory Stimulation for the Prevention of Delirium in Critically Ill ICU Patients: A Multicenter Prospective Randomized Controlled Trial
- Record updated
- 15 October 2026